BOT 4.29% 36.5¢ botanix pharmaceuticals ltd

Ann: Permetrex Outperforms Other CBD Topical Products, page-57

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 536 Posts.
    lightbulb Created with Sketch. 32
    How many pharmaceutical products (approved) are delivering CBD topically?
    Quality for organic and unregulated dose claims lower than advertised. Would expect so.
    Permetrex is being pitted against Betnovate® 0.1% Ointment in the psoriasis 1b trial.

    The test is a 3rd party validation. I wouldn't expect much else to come from it, as you said, unless they are exploring the OTC angle again for a cash flow injection.
    Surprised that the 1308 1b enrollment or completion has not been announced, inline with other 1b's.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
0.015(4.29%)
Mkt cap ! $707.4M
Open High Low Value Volume
35.0¢ 37.0¢ 34.5¢ $2.546M 7.049M

Buyers (Bids)

No. Vol. Price($)
5 280907 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 125495 3
View Market Depth
Last trade - 16.10pm 28/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.